Telomerase is a ribonucleoprotein enzyme that adds hexanucleotide repeats TTAGGG to the ends of chromosomes. Telomerase activation is known to play a crucial role in cell-immortalization and carcinogenesis. Telomerase is shown to have a correlation with cell cycle progression, which is controlled by the regulation of cyclins, cyclin dependent kinases (cdks) and cyclin dependent kinase inhibitors (cdkis). Abnormal expression of these regulatory molecules may cause alterations in cell cycle with uncontrolled cell growth, a universal feature of neoplasia. Skin cancer is the most prevalent form of cancer in humans and the solar UV radiation is its major cause. Here, we investigated modulation in telomerase activity and protein expression of cell cycle regulatory molecules during the development of UVBinduced tumors in SKH-1 hairless mice. The mice were exposed to 180 mjoules/cm 2 UVB radiation, thrice weekly for 24 weeks. The animals were sacri®ced at 4 week intervals and the studies were performed in epidermis. Telomerase activity was barely detectable in the epidermis of non-irradiated mouse. UVB exposure resulted in a progressive increase in telomerase activity starting from the 4th week of exposure. The increased telomerase activity either persisted or further increased with the increased exposure. In papillomas and carcinomas the enzyme activity was comparable and was 45-fold higher than in the epidermis of control mice. Western blot analysis showed an upregulation in the protein expression of cyclin D1 and cyclin E and their regulatory subunits cdk4 and cdk2 during the course of UVB exposure and in papillomas and carcinomas. The protein expression of cdk6 and ckis viz. p16/Ink4A, p21/Waf1 and p27/Kip1 did not show any signi®cant change in UVB exposed skin, but signi®cant upregulation was observed both in papillomas and carcinomas. The results suggest that telomerase activation may be involved in UVB-induced tumorigenesis in mouse skin and that increased telomerase activity may be associated with G1 phase of the cell cycle.
Introduction
In recent years, the involvement of telomerase activation is receiving increasing attention in the pathogenesis of cancer. Telomerase is a ribonucleoprotein enzyme that catalyses addition of hexanucleotide repeats (TTAGGG) n to telomeric termini using a segment of its endogenous RNA component as a template (Greider and Blackburn, 1985) . This process prevents chromosomes from fusing together and causing DNA rearrangements that can lead to karyotypic changes and genomic instability (Greider, 1991) . Telomerase activity is usually repressed or is undetectable in normal somatic cells except germ cells, hematopoietic cells, and proliferating cells of renewal tissues (Kim et al., 1994; Broccoli et al., 1995; Taylor et al., 1996; Yasumoto et al., 1996) . Although the mechanism of telomerase activation is not known, an association between its activation during cellular immortalization and expression in tumors led to the view that it may be required for tumor growth in vivo (Counter et al., 1992) . A number of studies have demonstrated that telomerase is activated in a variety of malignant tumors in experimental animals as well as in humans (Kim et al., 1994; Ueda et al., 1997; Yashima et al., 1998) .
Abnormal expression of cell cycle regulatory molecules may cause alterations in cell cycle resulting in an uncontrolled cell growth, a universal feature of neoplasia. Proliferation in mammalian cells is primarily achieved in the G1-phase of the cell cycle through the action of the G1 cyclins and their regulatory cyclin dependent kinases (cdks) (Hunter and Pines, 1994) . After G1-phase, the cells become largely independent of extracellular signals and progress automatically through subsequent cell cycle to the next G1-phase (Pardee 1989) . Cdk activities are regulated by a group of speci®c inhibitory proteins known as cyclin dependent kinase inhibitors (cdkis) (Hunter and Pines, 1994) . There are two families of cdkis namely cip/kip and ink families. The cip/kip family includes p21/Waf1/Cip1, p27/Kip1 and p57/Kip2, which share sequence homology and can inhibit the kinase activity of variety of cdks. The ink4 family consists of p16/ Ink4A, p15/Ink4B, p18/Ink4C and p19/Ink4D, which can speci®cally inhibit the kinase activity of cdk4/cdk6. Studies have shown an association between telomerase activity and cell proliferation in human tumor cells, as the terminal dierentiation and cell cycle exit is followed by down regulation of telomerase activity (Sharma et al., 1995; Holt et al., 1997) .
Not much is known about the association of telomerase activation with skin cancer, the most common human malignancy that is mainly caused by exposure of the skin to solar UV radiation. Using a mouse skin chemical carcinogenesis model, it has been demonstrated that telomerase activity increases progressively during premalignancy (Bednarek et al., 1995 (Bednarek et al., , 1997 . It has been reported that telomerase activity is upregulated during radiation-induced malignant transformation of human cells (Pandita et al., 1996) and in the sun-exposed skin in humans, indicating a possible modulation of telomerase activity by UV exposure (Taylor et al., 1996; Ueda et al., 1997) . To our knowledge, only a few studies have been reported about the relationship of telomerase activity and its association with the status of cell cycle regulatory molecules in tumors. In breast cancer, an association between high telomerase activity and overexpression of cyclin D1 and/or cyclin E has been reported (Landberg et al., 1997) . In cell lines from four immortalization complementation groups, no correlation between telomerase activity and abnormalities in RB, p53 and p16/Ink4 could be demonstrated, but all cell lines were defective in at least one of these components (Whitaker et al., 1995) . Therefore, a systematic study to investigate the association of telomerase activation with cell cycle regulatory molecules during tumor promotion and/or tumor progression is important. In this communication we provide evidence that telomerase activation occurs during UVB-induced tumorigenesis in mouse skin. Furthermore, we also provide data suggesting a possible association between cell cycle regulation and the activation of telomerase in mouse skin photocarcinogenesis.
Results
Telomerase activity in non-irradiated epidermis and progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice
The telomerase activity was barely detectable in the epidermis of normal (unexposed) SKH-1 hairless mice ( Figure 1a) . The skin exposure to UVB light, which is conventionally employed to induce tumors in this mouse strain, resulted in a progressive increase in telomerase activity starting from 4 weeks after the UVB exposure. The subsequent UVB exposures further increased the telomerase activity ( Figure 1a ). The quanti®cation of telomerase bands by densitometry showed that as compared to non-irradiated epidermis, the increase in telomerase activity at 4, 8, 12 and 16 weeks post-UVB exposure was 12-, 23-, 24-and 32-fold respectively. As compared to unexposed animals, telomerase activity was found to be 44-and 46-fold higher in papillomas and carcinomas (Figure 1b) .
G1 cyclins and cdks in epidermis of non-irradiated and progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice
As for the progression of cell through G1-phase, the cyclins and cdks operative in G1-phase play an important role, we analysed the protein expression of these cyclins and their regulatory cdks in the present study. Western blot analysis revealed that the levels of cyclins (D1 and E) and cdk 2 are signi®cantly upregulated following UVB exposure when compared to that in normal non-irradiated epidermis ( Figure 2a ). The quanti®cation of the protein bands by densitometric analysis showed a 2.1-, 3.1-and 3.8-fold increase in cyclin D1 protein expression at 8, 12 and 16 weeks of UVB exposure respectively as compared to that in control mice. In papillomas and carcinomas, 14-and 16-fold increases occurred respectively when compared to epidermis of unexposed animals ( Figure 2b ). The protein expression of cyclin E increased marginally at 4 and 8 weeks of UVB exposure, and 2.4-and 2.8-fold at 12 and 16 weeks of UVB exposure respectively. Compared to non-irradiated epidermis the papillomas and carcinomas respectively showed a four and tenfold elevation of cyclin E. The level of cdk2 also a b Figure 1 Telomerase activity in normal and progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice with SYBR green method (a) and densitometric quanti®cation of radioisotopic detection (b). The TRAPEZE TM Kit (Oncor, Gaithersburg, MD, USA) was used for telomerase assay as recommended by the manufacturer. The protein extract was prepared for normal and dierent stages of UVB-induced tumorigenesis by using CHAPS lysis buer and 2 ml of tissue extract (containing 0.6 mg protein) was used for the PCR assay. Heat inactivated sample (by incubating at 908C for 5 min prior to TRAP assay) was used as a negative control. Control template (TSR8, supplied with the kit) was used as a positive control. The PCR products were eletrophoresed on a 10% TBE gel (Novex) followed by SYBR Green 1 nucleic acid staining (Molecular Probes, Eugene, Oregon) and Polaroid photography. Lanes 1: Normal skin; 2. UVBexposed skin at 4 weeks; 3. UVB-exposed skin at 8 weeks; 4. UVB-exposed skin at 12 weeks; 5. UVB-exposed skin at 16 weeks; 6. Papillomas; 7. Carcinomas; 8. Heat inactivated sample and 9. Positive control. Data from a typical experiment repeated three times with similar result is shown. The details are described in Materials and methods showed 2.1-, 3.3-and 3.7-fold increases at 8, 12 and 16 weeks of UVB exposure respectively when compared to control. Furthermore, 12 and 13-fold increases in papillomas and carcinomas were observed when compared to non-irradiated epidermis. The protein expression of cdk4 was found to be increased only marginally during UVB exposure whereas cdk6 did not show any signi®cant change when compared to normal skin. However, signi®cant upregulation of both cdk4 (2.4-and 2.3-fold) and cdk6 were observed in papillomas and carcinomas (5.7-and 7.1-fold respectively) when compared to control.
Cyclin dependent kinase inhibitors (cdkis) in epidermis of non-irradiated and in progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice
Because the cdkis are potent negative regulators of the cell cycle, it has been suggested that they may also function as tumor suppressor genes and may play an important role in the development of human cancers (Hunter and Pines, 1994; Polyak et al., 1994) . In the present study, we analysed the protein expression of cdkis viz., p16/Ink4A, p21/Waf1 and p27/Kip1, which are operative in the G1 phase of the cell cycle. The protein expression of p16/Ink4A and p21/Waf1 was barely detectable in the epidermis of non-irradiated mice (Figure 3a) . However, p21/Waf1 and p27/kip1 was found to be induced by the UVB exposure in the epidermis of mice. Based on the densitometric analysis, UVB resulted in a 3.0-, 2.2-, 2.1-and 2.2-fold increase of p21/Waf1 at 4, 8, 12 and 16 weeks of exposure respectively when compared non-irradiated epidermis. In papillomas and carcinomas 35-and 37-fold increases occurred respectively when compared to epidermis of unexposed animals ( Figure 3b ). The protein expression of p27 was marginally increased at 4 and 8 weeks of UVB exposure whereas 2.0-and 1.8-fold higher levels were observed in the animals exposed at 12 and 16 weeks respectively. Compared to non-irradiated epidermis, 10.5-and 12.5-fold elevation of p27 in papillomas and carcinomas respectively was observed. The protein expression of p16/Ink4A did not show any signi®cant changes during UVB exposure. However, 71-and 86-fold increase of p16/Ink4A was observed in papillomas and carcinomas. a b Figure 2 Western blot analysis of cyclins and cdks in normal and progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice. (a) Protein expression and (b) densitometric quanti®cation of protein content. Protein lysates were prepared and 25 mg of protein was subjected to SDS ± PAGE followed by Western blot analysis using appropriate primary antibodies and secondary HRP conjugates. The proteins were detected by chemiluminescense. Lanes 1: Normal skin; 2. UVB-exposed skin at 4 weeks; 3. UVB-exposed skin at 8 weeks; 4. UVB-exposed skin at 12 weeks; 5. UVB-exposed skin at 16 weeks; 6. Papillomas and 7. Carcinomas. Data from a typical experiment repeated three times with similar result are shown here. The details are described in Materials and methods a b Figure 3 Western blot analysis of cdkis in normal and progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice. (a) Protein expression and (b) densitometric quanti®cation of protein content. Protein lysates were prepared and 25 mg of protein was subjected to SDS ± PAGE followed by Western blot analysis using appropriate primary antibodies and secondary HRP conjugates. The proteins were detected by chemiluminescense. Lanes 1: Normal skin; 2. UVB-exposed skin at 4 weeks; 3. UVB-exposed skin at 8 weeks; 4. UVB-exposed skin at 12 weeks; 5. UVB-exposed skin at 16 weeks; 6. Papillomas and 7. Carcinomas. Data from a typical experiment repeated three times with similar result are shown. The details are described in Materials and methods
Discussion
In the present study we investigated the modulation in (i) the telomerase activity, and (ii) the protein expression of cell cycle regulatory molecules, viz. cyclins, cdks and cdkis, during progressive stages of UVB-induced tumorigenesis in SKH-1 hairless mice. Telomerase activity has recently been detected in a variety of human immortal cell lines and primary tumor tissues and it has been proposed that the immortalization of human cells requires reactivation of telomerase (Kim et al., 1994) . Recent studies have also shown that in contrast to humans, almost all somatic tissues of mice and rats have detectable level of telomerase activity (Chadeneau et al., 1995; Blasco et al., 1996; Yoshimi et al., 1996) . The presence of telomerase activity in normal murine tissues was attributed to the presence of somatic stem cells in the tissues with regeneration potential, an idea similar to that reported in human epithelium (Yasumoto et al., 1996) and skin (Ueda et al., 1997) . However, the level of telomerase activity was shown to be substantially higher in rodent tumors compared to corresponding normal tissues (Chadeneau et al., 1995; Blasco et al., 1996; Yoshimi et al., 1996) . Blasco et al. (1996) described elevation of telomerase levels in the late stages of tumor progression in two dierent transgenic mouse models of multi-stage tumorigenesis and proposed that there is a dierential regulation of telomerase activity and telomerase RNA during tumorigenesis.
Elevated telomerase activity has also been reported in carcinogen-induced rat colon tumors (Yoshimi et al., 1996) , viral oncogene-induced pancreatic tumors (Chadeneau et al., 1995) and mammary tumors from neu transgenic mice (Blasco et al., 1996) . However, in the normal mouse tissue including skin, the telomerase activity was not detectable (Bednarek et al., 1995) . Consistent with these ®ndings, in the present study, telomerase activity was barely detectable in the epidermis of non-irradiated mouse. However, a signi®cant upregulation of telomerase activity was observed in the skin at 4 weeks of UVB exposure. Higher expression of telomerase activity in UVBinduced papillomas and carcinomas observed in this study is similar to earlier studies in mouse skin papillomas and tumors induced by chemical carcinogens (Bednarek et al., 1995 (Bednarek et al., , 1997 . Our data showing an increase of telomerase activity during progressive stages of UVB tumorigenesis suggest that UVB exposure results in activation of telomerase and the activation occurs at an early stage of photocarcinogenesis.
Recent studies have shown an association between telomerase activity and cell proliferation in human tumor cells, as terminal dierentiation and cell cycle exit is followed by down regulation of telomerase activity (Sharma et al., 1995; Holt et al., 1997) . Telomerase activity is an immortalization marker that is found in most cancers and for which an active cell cycle has been implicated. Landberg et al. (1997) have recently reported a positive correlation between telomerase activity and overexpression of cyclin D1 and/or cyclin E in human breast cancer. Therefore, it was of interest to us to study a possible correlation between telomerase activity and its association with cell cycle dysregulation during UVBinduced photocarcinogenesis in mouse skin. Proliferation in mammalian cells is primarily achieved in the G1-phase of the cell cycle through the action of the G1 cyclin/cdk complexes. After G1, cells become largely independent of extracellular signals and progress automatically through subsequent cell cycle to the G1 phase (Pardee, 1989) . There is increasing evidence that several types of experimental animal and human tumors display abnormalities in cell cycle regulatory genes (Bianchi et al., 1993; Kawamata et al., 1995; Sgambato et al., 1995; Landberg et al., 1997; Balasubramanian et al., 1998) . Therefore we examined the protein expression of G1 cyclins and their associated cdks during UVBinduced phtocarcinogenesis.
Western blot analysis data revealed that the levels of cyclins D1 and E and are signi®cantly upregulated at an early stage of UVB-induced photocarcinogenesis (Figure 2a,b) . The level of cdk2 also showed 2.1-, 3.3-and 3.7-fold increases at 8, 12 and 16 weeks of UVB exposure respectively when compared to control. Furthermore, 12-and 13-fold increases in papillomas and carcinomas were noticed when compared to nonirradiated epidermis. Although the protein expression of cdk4 and cdk6 did not show any signi®cant changes during UVB treatment, signi®cant upregulation was observed in papillomas and carcinomas. These data suggest that these cdks play a role in later stages of UVB-induced tumorigenesis. It has been shown that overexpression of cyclin D1 can enhance genomic instability, and also accelerate the process of tumor progression (Zhou et al., 1995) . Zhang et al. (1997) reported that abnormal upregulation of cyclin D1/cdk4 is an early event in intestinal carcinogenesis and associated with malignant progression. The cyclin E gene is also often deregulated and overexpressed in human breast and colorectal carcinomas (Buckley et al., 1993; Leach et al., 1993) . Increased expression of cyclins (D1 and E) and cdks (2 and 4) is reported to be associated with N-methyl-N-nitrosourea-induced primary rat mammary tumors (Sgambato et al., 1995) . Since we have also observed upregulation of G1 cyclins and their associated cdks, our data suggest that in addition to telomerase activation, deregulation of the cell cycle in G1 phase may also be a critical event during UVB-induced tumorigenesis.
It is known that the cyclin dependent kinase inhibitors (cdkis) can bind to and inhibit the cyclin/ cdk complexes. The cdkis have attracted considerable interest because of their potential as tumor suppressors (Hunter and Pines, 1994) and as they play an important role in cell growth and dierentiation Polyak et al., 1994) . Therefore we also examined the protein expression of cdkis operative in G1-phase of the cell cycle viz., p16/Ink4A, p21/Waf1 and p27/Kip1 during UVB-induced photocarcinogenesis. p16/Ink4A is known to inhibit Cyclin D-cdk4/ cdk6 complex, resulting in the dephosphorylation of pRB and related G1 growth arrest (Serrano et al., 1993) . The p21/Waf1 gene encodes a 21-kd nucleoprotein, which in normal human cells exists in quaternary complexes with proliferating-cell nuclear antigen, a cyclin, and a cdk (Li et al., 1994) . The expression of p16/Ink4A and p21/waf1 was undetectable in the epidermis of non-irradiated mice whereas p27/Kip1 was found to be less expressed. The expression of these cdkis did not show any signi®cant changes during UVB exposure but signi®cant upregulation was observed in papillomas and carcinomas. These data suggest that cdkis may be involved in late stages of tumor development. Tron et al. (1996) recently reported the upregulation of p21 waf1 is associated with dierentiation in proliferating human cutaneous squamous cell carcinoma but the increase is not sucient to suppress cancer development. Abnormalities in the gene expression of cdkis in various cancers have also been reported (Linardopoulos et al., 1995; Ponce-Castaneda et al., 1995; Tron et al., 1996) . Since during the course of tumor formation the repeated exposure of UVB provides proliferative signals thereby resulting in the induction of cdkis which possibly could limit, but is not sucient (due to the repetitive proliferative signals), the proliferation by inhibition of cyclin/cdk complexes. Recently, Engelhardt et al. (1997) have reported that proliferation of ex vivo expanded human CD34 + cells and cell cycle activation in response to cytokine support was closely linked with telomerase upregulation and induction of cell cycle regulatory proteins involved in the G1/S phase progression.
The overexpression of G1 cyclins and cdks observed in the present study may be responsible for the phosphorylation of pRB and thereby promoting G1-S phase transition of the cell cycle. Although there is upregulation of ckis expression, the ratio of cyclins/ cdks to ckis and binding between these molecules may be a critical factor in UVB-induced tumorigenesis. Our data suggest that telomerase activation is involved in UVB-induced tumorigenesis in mouse skin and that telomerase activity may be associated with the progression of cell cycle in G1 phase through cyclincdk-cdki network. Since UVB tumor protocols in SKH-1 hairless mice have been considered to have relevance to human skin cancer, our data may be applicable to human skin cancer. However, humans are continuously exposed to low doses of UVA and UVB. To ®rmly establish the relevance of our ®ndings in mice reported here to human skin cancer, additional work is required.
Materials and methods

Animals and UVB light source
Six-weeks-old female SKH-1 hairless mice obtained from Charles River Laboratories (Wilmington, MA, USA) were used for this study. The animals were acclimatized for 1 week before use and subjected to a 12 h light/12 h dark cycle, housed at 24+208C and 50+10% relative humidity in a room with 12 ± 15 cycles of air exchange/h and fed ad libitum purina lab chow. For UVB irradiation, the mice were housed in specially designed cages where they were held in dividers separated by Plexiglas. The distance between light source to target skin was 23 cm in all of the UVB irradiations (Katiyar et al., 1997) . The UVB light source used was a bank of four uorescent sunlamps equipped with a UVB Spectrum 305 Dosimeter (Daavlin Co., Bryan, OH, USA). This light source emitted about 80% radiation in the range of 280 ± 340 nm, with peak emission at 314 nm as monitored with an SEE 240 photodetecter, 103 ®lter, and 1008 diuser attached to an IL 700 Research radiometer (International Light, Newburyport, MA, USA). The mice were exposed to 180 mjoules/cm 2 UVB radiation, thrice weekly and the animals were withdrawn at 0, 4, 8, 12 and 16 weeks after the treatment. The UVB exposure was continued in remaining animals and papillomas and carcinomas developed between 24 ± 36 weeks were removed. Unexposed animals maintained at standard housing conditions served as controls. No signi®cant age related dierences in the basal activities of any of the parameters examined were evident (data not shown). The animals were sacri®ced at 4 week intervals by cervical dislocation and the dorsal skin was removed and made free of connective tissue and fat. The epidermis was separated from the whole skin by brief heat treatment at 558C for 30 s as described earlier (Das et al., 1987) . All tissues were snap frozen in liquid nitrogen and stored in 7808C until extracts for telomerase and immunoblotting were prepared. Tissues from three animals of each group were pooled together and used as one sample for the studies.
Telomerase assay
We employed the TRAPEZE TM Kit (Oncor, Gaithersburg, MD, USA) for detection of telomerase activity as per the protocol recommended by the manufacturer. This assay is based on the telomeric repeat ampli®cation protocol (TRAP) assay that involves the addition of TTAGGG repeats by telomerase to an oligonucleotide (TS), and the subsequent PCR ampli®cation of these extension products with both the forward (TS) and reverse (CX) primers (Kim et al., 1994) . Brie¯y, approximately 50 ± 100 mg of the tissue sample was homogenized in 100 ± 200 ml of ice-cold CHAPS lysis buer and kept on ice for 30 min. The lysate was then centrifuged at 12 000 g for 30 min at 48C and the supernatant was stored at 7808C until use. Protein concentration was determined by DC Bio-Rad assay. In pilot experiments we performed the assay with concentrations of proteins ranging from 0.01 ± 1.0 mg of protein. A concentration up to 0.6 mg was found to be in the linear range and this concentration was used in comparative studies. For the PCR reaction, 2 ml of the extract was combined with 48 ml of the reaction mixture supplied with the kit and 2 units of Taq DNA polymerase (GIBCO/ BRL). After incubation at 308C for 30 min for telomerase extension reaction, the samples were heated at 908C for 5 min to inactivate telomerase activity followed by PCR. Heat inactivated sample (by incubating at 908C for 5 min prior to TRAP assay) was used as a negative control. Control template (TSR8, supplied with the kit) was used as a positive control. The PCR products were eletrophoresed on a 10% TBE gel (Novex) followed by SYBR Green 1 nucleic acid staining (Molecular Probes, Eugene, OR, USA) and Polaroid photography. We also utilized the TRAPEZE TM Kit (Oncor, Gaithersburg, MD, USA) for comparative quantitation of telomerase activity using radioisotopic detection [g- 32 P]ATP method as recommended by the manufacturer. The PCR products were eletrophoresed on a 10% TBE gel (Novex). The gel was then dried; exposed for 2 ± 3 h and the telomerase ladders were quanti®ed by densitometry (SciScan TM 5000; United States Biochemical).
Preparation of protein lysates and Western blot analysis
The epidermal tissues were homogenized in ice-cold lysis buer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 20 mM NaF, 100 mM Na 3 VO 4 , 0.5% NP-40, 1% Triton X-100, 1 mM PMSF, 10 aprotinin, 10 mg/ml leupeptin; pH 7.4) in a microfuge tube and placed over ice for 30 min. The lysate was centrifuged at 14 000 g for 15 min at 48C. The supernatant (total cell lysate) was either used immediately or stored at 7808C. Protein concentration was determined by using Bio-Rad DC protein assay kit as per the manufacturer's protocol. For immunoblot analysis, the cell lysates containing 25 mg protein were denatured by heating over the boiling water with an equal volume of 26 sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) sample buer and then subjected to electrophoresis on 12 to 16% SDS-polyacrylamide gel (Novex). The proteins were then transferred onto a nitrocellulose membrane. The non-speci®c sites were blocked by incubating the blot with 5% non-fat dairy milk in buer (containing 10 mM Tris, 100 mM NaCl, 0.1% T-20) for 1 h at room temperature or overnight at 48C. The blot was then incubated with appropriate polyclonal antibody speci®c for the protein to be assessed, for 1 h at room temperature or overnight at 48C. The rabbit polyclonal antibodies against cyclin E, cdk 6, p16/Ink4A and p21/Waf1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and the goat polyclonal antibodies against cyclin D1, cdk 2, cdk 4 and p27/Kip1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) were used in this study. The antibodies were used at dilutions speci®ed by the manufacturer. The blot was washed for 2610 min and then incubated with the corresponding conjugated anti-rabbit IgG-HRP (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) or anti-goat IgG-HRP (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at 1 : 2000 dilution for either 1 h at room temperature or overnight at 48C. The blot was washed for 2610 min, 465 min and the protein was detected by chemluminescent-detection with ECL TM kit (Amersham Intl., Buckinghamshire, England). The relative intensity of the protein bands was quanti®ed by densitometry (SciScan TM 5000; United States Biochemical).
